Mesenchymal Stem Cell Transplantation: Neuroprotection and Nerve Regeneration After Spinal Cord Injury

References

• Sterner RC, Sterner RM. Immune response following traumatic spinal cord injury: pathophysiology and therapies. Front Immunol. 2022;13:1084101. doi:10.3389/fimmu.2022.1084101
   PubMed Web of Science ®Google Scholar
• Chen C, Qiao X, Liu W, Fekete C, Reinhardt JD. Epidemiology of spinal cord injury in China: a systematic review of the Chinese and English literature. Spinal Cord. 2022;60(12):1050–1061. doi:10.1038/s41393-022-00826-6
   PubMed Web of Science ®Google Scholar
• Borg SJ, Geraghty T, Arora M, et al. Employment outcomes following spinal cord injury: a population- based cross-sectional study in Australia. Spinal Cord. 2021;59(10):1120–1131. doi:10.1038/s41393-021-00639-z
   PubMed Web of Science ®Google Scholar
• Xia Y, Zhu J, Yang R, Wang H, Li Y, Fu C. Mesenchymal stem cells in the treatment of spinal cord injury: mechanisms, current advances and future challenges. Front Immunol. 2023;14:1141601. doi:10.3389/fimmu.2023.1141601
   PubMed Web of Science ®Google Scholar
• Dias DO, Kalkitsas J, Kelahmetoglu Y, et al. Pericyte-derived fibrotic scarring is conserved across diverse central nervous system lesions. Nat Commun. 2021;12(1):5501. doi:10.1038/s41467-021-25585-5
   PubMed Web of Science ®Google Scholar
• Clifford T, Finkel Z, Rodriguez B, Joseph A, Cai L. Current advancements in spinal cord injury research- Glial scar formation and neural regeneration. Cells. 2023;12(6):853. doi:10.3390/cells12060853
   PubMed Web of Science ®Google Scholar
• Sykova E, Cizkova D, Kubinova S. Mesenchymal Stem cells in treatment of spinal cord injury and amyotrophic lateral sclerosis. Front Cell Dev Biol. 2021;9:695900. doi:10.3389/fcell.2021.695900
   PubMed Web of Science ®Google Scholar
• Jin Y, Yang S, Zhang X. Retraction: reduction of neuronal damage and promotion of locomotor recovery after spinal cord injury by early administration of methylprednisolone: possible involvement of autophagy pathway. RSC Adv. 2022;12(41):26565. doi:10.1039/D2RA90087D
   PubMed Web of Science ®Google Scholar
• Chio JCT, Xu KJ, Popovich P, David S, Fehlings MG. Neuroimmunological therapies for treating spinal cord injury: evidence and future perspectives. Exp Neurol. 2021;341:113704.
   PubMed Web of Science ®Google Scholar
• Canseco JA, Karamian BA, Bowles DR, et al. Updated review: the steroid controversy for management of spinal cord injury. World Neurosurg. 2021;150:1–8. doi:10.1016/j.wneu.2021.02.116
   PubMed Web of Science ®Google Scholar
• Yang CH, Quan ZX, Wang GJ, et al. Elevated intraspinal pressure in traumatic spinal cord injury is a promising therapeutic target. Neural Regen Res. 2022;17(8):1703–1710. doi:10.4103/1673-5374.332203
   PubMed Web of Science ®Google Scholar
• Teoh PL, Mohd Akhir H, Abdul Ajak W, Hiew VV. Human mesenchymal stromal cells derived from perinatal tissues: sources, characteristics and isolation methods. Malays J Med Sci. 2023;30(2):55–68. doi:10.21315/mjms2023.30.2.5
   PubMed Web of Science ®Google Scholar
• Barbon S, Rajendran S, Bertalot T, et al. Growth and differentiation of circulating stem cells after extensive ex vivo expansion. Tissue Eng Regen Med. 2021;18(3):411–427. doi:10.1007/s13770-021-00330-7
   PubMed Web of Science ®Google Scholar
• Pievani A, Scagliotti V, Russo FM, et al. Comparative analysis of multilineage properties of mesenchymal stromal cells derived from fetal sources shows an advantage of mesenchymal stromal cells isolated from cord blood in chondrogenic differentiation potential. Cytotherapy. 2014;16(7):893–905. doi:10.1016/j.jcyt.2014.02.008
   PubMed Web of Science ®Google Scholar
• Laloze J, Fievet L, Desmouliere A. Adipose-derived mesenchymal stromal cells in regenerative medicine: state of play, current clinical trials, and future prospects. Adv Wound Care (New Rochelle). 2021;10(1):24–48. doi:10.1089/wound.2020.1175
   PubMed Web of Science ®Google Scholar
• Moayeri A, Alizadeh R, Ghasemi Hamidabadi H, et al. Transdifferentiation of human umbilical cord-derived mesenchymal stem cells in dopaminergic neurons in a three-dimensional culture. Basic Clin Neurosci. 2022;13(5):625–636. doi:10.32598/bcn.2021.973.3
   PubMed Web of Science ®Google Scholar
• Han Y, Li X, Zhang Y, Han Y, Chang F, Ding J. Mesenchymal stem cells for regenerative medicine. Cells. 2019;8(8):886. doi:10.3390/cells8080886
   PubMed Web of Science ®Google Scholar
• Kim M, Kim KH, Song SU, et al. Transplantation of human bone marrow-derived clonal mesenchymal stem cells reduce fibrotic scar formation in a rat spinal cord injury model. J Tissue Eng Regen Med. 2018;12(2):e1034–e1045. doi:10.1002/term.2425
   PubMed Web of Science ®Google Scholar
• Liao Y, Ming J, Song W, et al. Mitochondrial transplantation and immune response of human bone marrow mesenchymal stem cells for the Therapeutic of ischemic stroke. Curr Stem Cell Res Ther. 2023. doi:10.2174/1574888X18666230505103407
   Google Scholar
• Spees JL, Lee RH, Gregory CA. Mechanisms of mesenchymal stem/stromal cell function. Stem Cell Res Ther. 2016;7(1):125. doi:10.1186/s13287-016-0363-7
   PubMed Web of Science ®Google Scholar
• Maeda Y, Otsuka T, Takeda M, et al. Transplantation of rat cranial bone-derived mesenchymal stem cells promotes functional recovery in rats with spinal cord injury. Sci Rep. 2021;11(1):21907. doi:10.1038/s41598-021-01490-1
   PubMed Web of Science ®Google Scholar
• Zhou Z, Tian X, Mo B, et al. Adipose mesenchymal stem cell transplantation alleviates spinal cord injury-induced neuroinflammation partly by suppressing the Jagged1/Notch pathway. Stem Cell Res Ther. 2020;11(1):212. doi:10.1186/s13287-020-01724-5
   PubMed Web of Science ®Google Scholar
• Li L, Cao J, Li S, et al. M2 macrophage-derived sEV regulate pro-inflammatory CCR2(+) macrophage subpopulations to favor post-AMI cardiac repair. Adv Sci (Weinh). 2023;10(14):e2202964. doi:10.1002/advs.202202964
   PubMedGoogle Scholar
• Lin H, Sohn J, Shen H, Langhans MT, Tuan RS. Bone marrow mesenchymal stem cells: aging and tissue engineering applications to enhance bone healing. Biomaterials. 2019;203:96–110. doi:10.1016/j.biomaterials.2018.06.026
   PubMed Web of Science ®Google Scholar
• Sun J, Xing F, Zou M, Gong M, Li L, Xiang Z. Correction: comparison of chondrogenesis-related biological behaviors between human urine-derived stem cells and human bone marrow mesenchymal stem cells from the same individual. Stem Cell Res Ther. 2022;13(1):514. doi:10.1186/s13287-022-03193-4
   PubMed Web of Science ®Google Scholar
• Shirin M, Agharezaeei M, Alizadeh S, et al. A comparative study of the bone marrow- and umbilical cord-derived Mesenchymal Stem Cells (MSCs) Efficiency on Generating MSC-Educated Macrophages (MEMs). Asian Pac J Cancer Prev. 2022;23(9):3083–3092. doi:10.31557/APJCP.2022.23.9.3083
   PubMedGoogle Scholar
• Cofano F, Boido M, Monticelli M, et al. Mesenchymal stem cells for spinal cord injury: current options, limitations, and future of cell therapy. Int J Mol Sci. 2019;20(11):2698. doi:10.3390/ijms20112698
   PubMed Web of Science ®Google Scholar
• Fu X, Liu G, Halim A, Ju Y, Luo Q, Song AG. Mesenchymal stem cell migration and tissue repair. Cells. 2019;8(8):784. doi:10.3390/cells8080784
   PubMed Web of Science ®Google Scholar
• Tahmasebi F, Barati S. Effects of mesenchymal stem cell transplantation on spinal cord injury patients. Cell Tissue Res. 2022;389(3):373–384. doi:10.1007/s00441-022-03648-3
   PubMed Web of Science ®Google Scholar
• Karamouzian S, Nematollahi-Mahani SN, Nakhaee N, Eskandary H. Clinical safety and primary efficacy of bone marrow mesenchymal cell transplantation in subacute spinal cord injured patients. Clin Neurol Neurosurg. 2012;114(7):935–939. doi:10.1016/j.clineuro.2012.02.003
   PubMed Web of Science ®Google Scholar
• Ahuja CS, Nori S, Tetreault L, et al. Traumatic spinal cord injury-repair and regeneration. Neurosurgery. 2017;80(3S):S9–S22. doi:10.1093/neuros/nyw080
   PubMed Web of Science ®Google Scholar
• Anjum A, Yazid MD, Fauzi Daud M, et al. Spinal cord injury: pathophysiology, multimolecular interactions, and underlying recovery mechanisms. Int J Mol Sci. 2020;21(20):7533. doi:10.3390/ijms21207533
   PubMed Web of Science ®Google Scholar
• Lee CY, Chooi WH, Ng SY, Chew SY. Modulating neuroinflammation through molecular, cellular and biomaterial-based approaches to treat spinal cord injury. Bioeng Transl Med. 2023;8(2):e10389. doi:10.1002/btm2.10389
   PubMed Web of Science ®Google Scholar
• Hachem LD, Fehlings MG. Pathophysiology of spinal cord injury. Neurosurg Clin N Am. 2021;32(3):305–313. doi:10.1016/j.nec.2021.03.002
   PubMed Web of Science ®Google Scholar
• Zhang Y, Al Mamun A, Yuan Y, et al. Acute spinal cord injury: pathophysiology and pharmacological intervention (Review). Mol Med Rep. 2021;23(6). doi:10.3892/mmr.2021.12056
   Web of Science ®Google Scholar
• Alizadeh A, Dyck SM, Karimi-Abdolrezaee S. Traumatic spinal cord injury: an overview of pathophysiology, models and acute injury mechanisms. Front Neurol. 2019;10:282.
   PubMed Web of Science ®Google Scholar
• Conforti L, Gilley J, Coleman MP. Wallerian degeneration: an emerging axon death pathway linking injury and disease. Nat Rev Neurosci. 2014;15(6):394–409. doi:10.1038/nrn3680
   PubMed Web of Science ®Google Scholar
• O’Shea TM, Burda JE, Sofroniew MV. Cell biology of spinal cord injury and repair. J Clin Invest. 2017;127(9):3259–3270. doi:10.1172/JCI90608
   PubMed Web of Science ®Google Scholar
• Eli I, Lerner DP, Ghogawala Z. Acute traumatic spinal cord injury. Neurol Clin. 2021;39(2):471–488. doi:10.1016/j.ncl.2021.02.004
   PubMed Web of Science ®Google Scholar
• Haggerty AE, Maldonado-Lasuncion I, Oudega M. Biomaterials for revascularization and immunomodulation after spinal cord injury. Biomed Mater. 2018;13(4):044105. doi:10.1088/1748-605X/aaa9d8
   PubMed Web of Science ®Google Scholar
• Yao C, Cao X, Yu B. Revascularization after traumatic spinal cord injury. Front Physiol. 2021;12:631500. doi:10.3389/fphys.2021.631500
   PubMed Web of Science ®Google Scholar
• Oudega M. Molecular and cellular mechanisms underlying the role of blood vessels in spinal cord injury and repair. Cell Tissue Res. 2012;349(1):269–288. doi:10.1007/s00441-012-1440-6
   PubMed Web of Science ®Google Scholar
• Wu X, Yan Y, Zhang Q. Neuroinflammation and Modulation role of natural products after spinal cord injury. J Inflamm Res. 2021;14:5713–5737. doi:10.2147/JIR.S329864
   PubMed Web of Science ®Google Scholar
• Yao XQ, Liu ZY, Chen JY, et al. Proteomics and bioinformatics reveal insights into neuroinflammation in the acute to subacute phases in rat models of spinal cord contusion injury. FASEB J. 2021;35(7):e21735. doi:10.1096/fj.202100081RR
   PubMed Web of Science ®Google Scholar
• Garcia E, Aguilar-Cevallos J, Silva-Garcia R, Ibarra A. Cytokine and growth factor activation in vivo and in vitro after spinal cord injury. Mediators Inflamm. 2016;2016:9476020. doi:10.1155/2016/9476020
   PubMed Web of Science ®Google Scholar
• Beck KD, Nguyen HX, Galvan MD, Salazar DL, Woodruff TM, Anderson AJ. Quantitative analysis of cellular inflammation after traumatic spinal cord injury: evidence for a multiphasic inflammatory response in the acute to chronic environment. Brain. 2010;133(Pt 2):433–447. doi:10.1093/brain/awp322
   PubMedGoogle Scholar
• Pang QM, Chen SY, Fu SP, et al. Regulatory role of mesenchymal stem cells on secondary inflammation in spinal cord injury. J Inflamm Res. 2022;15:573–593. doi:10.2147/JIR.S349572
   PubMed Web of Science ®Google Scholar
• Ulndreaj A, Chio JC, Ahuja CS, Fehlings MG. Modulating the immune response in spinal cord injury. Expert Rev Neurother. 2016;16(10):1127–1129. doi:10.1080/14737175.2016.1207532
   PubMed Web of Science ®Google Scholar
• David S, Lopez-Vales R. Bioactive lipid mediators in the initiation and resolution of inflammation after spinal cord injury. Neuroscience. 2021;466:273–297. doi:10.1016/j.neuroscience.2021.04.026
   PubMed Web of Science ®Google Scholar
• Dolma S, Kumar H. Neutrophil, extracellular matrix components, and their interlinked action in promoting secondary pathogenesis after spinal cord injury. Mol Neurobiol. 2021;58(9):4652–4665. doi:10.1007/s12035-021-02443-5
   PubMed Web of Science ®Google Scholar
• Miron VE, Franklin RJ. Macrophages and CNS remyelination. J Neurochem. 2014;130(2):165–171. doi:10.1111/jnc.12705
   PubMed Web of Science ®Google Scholar
• Fehlings MG, Nakashima H, Nagoshi N, Chow DS, Grossman RG, Kopjar B. Rationale, design and critical end points for the Riluzole in Acute Spinal Cord Injury Study (RISCIS): a randomized, double-blinded, placebo-controlled parallel multi-center trial. Spinal Cord. 2016;54(1):8–15. doi:10.1038/sc.2015.95
   PubMed Web of Science ®Google Scholar
• Vanzulli I, Butt AM. mGluR5 protect astrocytes from ischemic damage in postnatal CNS white matter. Cell Calcium. 2015;58(5):423–430. doi:10.1016/j.ceca.2015.06.010
   PubMed Web of Science ®Google Scholar
• Hall ED, Wang JA, Bosken JM, Singh IN. Lipid peroxidation in brain or spinal cord mitochondria after injury. J Bioenerg Biomembr. 2016;48(2):169–174. doi:10.1007/s10863-015-9600-5
   PubMed Web of Science ®Google Scholar
• Pandya JD, Musyaju S, Modi HR, et al. Comprehensive evaluation of mitochondrial redox profile, calcium dynamics, membrane integrity and apoptosis markers in a preclinical model of severe penetrating traumatic brain injury. Free Radic Biol Med. 2023;198:44–58. doi:10.1016/j.freeradbiomed.2023.02.001
   PubMed Web of Science ®Google Scholar
• Golpich M, Amini E, Mohamed Z, Azman Ali R, Mohamed Ibrahim N, Ahmadiani A. Mitochondrial dysfunction and biogenesis in neurodegenerative diseases: pathogenesis and treatment. CNS Neurosci Ther. 2017;23(1):5–22. doi:10.1111/cns.12655
   PubMed Web of Science ®Google Scholar
• Scholpa NE, Schnellmann RG. Mitochondrial-based therapeutics for the treatment of spinal cord injury: mitochondrial biogenesis as a potential pharmacological target. J Pharmacol Exp Ther. 2017;363(3):303–313. doi:10.1124/jpet.117.244806
   PubMed Web of Science ®Google Scholar
• Hall ED. Antioxidant therapies for acute spinal cord injury. Neurotherapeutics. 2011;8(2):152–167. doi:10.1007/s13311-011-0026-4
   PubMed Web of Science ®Google Scholar
• Lee BJ, Jeong JH. Review: steroid use in patients with acute spinal cord injury and guideline update. Korean J Neurotrauma. 2022;18(1):22–30. doi:10.13004/kjnt.2022.18.e21
   PubMedGoogle Scholar
• Singh IN, Sullivan PG, Deng Y, Mbye LH, Hall ED. Time course of post-traumatic mitochondrial oxidative damage and dysfunction in a mouse model of focal traumatic brain injury: implications for neuroprotective therapy. J Cereb Blood Flow Metab. 2006;26(11):1407–1418. doi:10.1038/sj.jcbfm.9600297
   PubMed Web of Science ®Google Scholar
• Sullivan PG, Krishnamurthy S, Patel SP, Pandya JD, Rabchevsky AG. Temporal characterization of mitochondrial bioenergetics after spinal cord injury. J Neurotrauma. 2007;24(6):991–999. doi:10.1089/neu.2006.0242
   PubMed Web of Science ®Google Scholar
• Wang B, Huang M, Shang D, Yan X, Zhao B, Zhang X. Mitochondrial behavior in Axon Degeneration and regeneration. Front Aging Neurosci. 2021;13:650038. doi:10.3389/fnagi.2021.650038
   PubMed Web of Science ®Google Scholar
• Cohen-Adad J, El Mendili MM, Lehericy S, et al. Demyelination and degeneration in the injured human spinal cord detected with diffusion and magnetization transfer MRI. Neuroimage. 2011;55(3):1024–1033. doi:10.1016/j.neuroimage.2010.11.089
   PubMed Web of Science ®Google Scholar
• Domingues HS, Portugal CC, Socodato R, Relvas JB. Oligodendrocyte, astrocyte, and microglia crosstalk in myelin development, damage, and repair. Front Cell Dev Biol. 2016;4:71. doi:10.3389/fcell.2016.00071
   PubMed Web of Science ®Google Scholar
• Ginet V, Spiehlmann A, Rummel C, et al. Involvement of autophagy in hypoxic-excitotoxic neuronal death. Autophagy. 2014;10(5):846–860. doi:10.4161/auto.28264
   PubMed Web of Science ®Google Scholar
• Anderson MA. Targeting central nervous system regeneration with cell type specificity. Neurosurg Clin N Am. 2021;32(3):397–405. doi:10.1016/j.nec.2021.03.011
   PubMed Web of Science ®Google Scholar
• Assinck P, Duncan GJ, Hilton BJ, Plemel JR, Tetzlaff W. Cell transplantation therapy for spinal cord injury. Nat Neurosci. 2017;20(5):637–647. doi:10.1038/nn.4541
   PubMed Web of Science ®Google Scholar
• Moretti M, Caraffi R, Lorenzini L, et al. ”Combo” multi-target pharmacological therapy and new formulations to reduce inflammation and improve endogenous remyelination in traumatic spinal cord injury. Cells. 2023;12(9):1331. doi:10.3390/cells12091331
   PubMed Web of Science ®Google Scholar
• Li L, Acioglu C, Heary RF, Elkabes S. Role of astroglial toll-like receptors (TLRs) in central nervous system infections, injury and neurodegenerative diseases. Brain Behav Immun. 2021;91:740–755. doi:10.1016/j.bbi.2020.10.007
   PubMed Web of Science ®Google Scholar
• Orr MB, Gensel JC. Spinal cord injury scarring and inflammation: therapies targeting glial and inflammatory responses. Neurotherapeutics. 2018;15(3):541–553. doi:10.1007/s13311-018-0631-6
   PubMed Web of Science ®Google Scholar
• Tran AP, Warren PM, Silver J. The biology of regeneration failure and success after spinal cord injury. Physiol Rev. 2018;98(2):881–917. doi:10.1152/physrev.00017.2017
   PubMed Web of Science ®Google Scholar
• Gong Z, Xia K, Xu A, et al. Stem cell transplantation: a promising therapy for spinal cord injury. Curr Stem Cell Res Ther. 2020;15(4):321–331. doi:10.2174/1574888X14666190823144424
   PubMed Web of Science ®Google Scholar
• Nurkovic J, Dolicanin Z, Mustafic F, et al. Mesenchymal stem cells in regenerative rehabilitation. J Phys Ther Sci. 2016;28(6):1943–1948. doi:10.1589/jpts.28.1943
   PubMedGoogle Scholar
• Shao A, Tu S, Lu J, Zhang J. Crosstalk between stem cell and spinal cord injury: pathophysiology and treatment strategies. Stem Cell Res Ther. 2019;10(1):238. doi:10.1186/s13287-019-1357-z
   PubMed Web of Science ®Google Scholar
• Bao CS, Li XL, Liu L, Wang B, Yang FB, Chen LG. Transplantation of Human umbilical cord mesenchymal stem cells promotes functional recovery after spinal cord injury by blocking the expression of IL-7. Eur Rev Med Pharmacol Sci. 2018;22(19):6436–6447. doi:10.26355/eurrev_201810_16056
   PubMed Web of Science ®Google Scholar
• Yamazaki K, Kawabori M, Seki T, Houkin K. Clinical trials of stem cell treatment for spinal cord injury. Int J Mol Sci. 2020;21(11):3994. doi:10.3390/ijms21113994
   PubMed Web of Science ®Google Scholar
• Mothe AJ, Bozkurt G, Catapano J, et al. Intrathecal transplantation of stem cells by lumbar puncture for thoracic spinal cord injury in the rat. Spinal Cord. 2011;49(9):967–973.44. doi:10.1038/sc.2011.46
   PubMed Web of Science ®Google Scholar
• Oh SK, Jeon SR. Current concept of stem cell therapy for spinal cord injury: a review. Korean J Neurotrauma. 2016;12(2):40–46.42. doi:10.13004/kjnt.2016.12.2.40
   PubMedGoogle Scholar
• Zachar L, Bačenková D, Rosocha J. Activation, homing, and role of the mesenchymal stem cells in the inflammatory environment. J Inflamm Res. 2016;9:231–240. doi:10.2147/JIR.S121994
   PubMedGoogle Scholar
• Alvites R, Branquinho M, Sousa AC, Lopes B, Sousa P, Maurício AC. Mesenchymal stem/stromal cells and their paracrine activity-immunomodulation mechanisms and how to influence the therapeutic potential. Pharmaceutics. 2022;14(2):381. doi:10.3390/pharmaceutics14020381
   PubMed Web of Science ®Google Scholar
• Deng QJ, Xu XF, Ren J. Correction to: effects of SDF-1/CXCR4 on the repair of traumatic brain injury in rats by mediating bone marrow derived mesenchymal stem cells. Cell Mol Neurobiol. 2021;41(3):617–618. doi:10.1007/s10571-020-00932-0
   PubMed Web of Science ®Google Scholar
• Dubon MJ, Yu J, Choi S, Park KS. Transforming growth factor beta induces bone marrow mesenchymal stem cell migration via noncanonical signals and N-cadherin. J Cell Physiol. 2018;233(1):201–213. doi:10.1002/jcp.25863
   PubMed Web of Science ®Google Scholar
• Liu L, Luo Q, Sun J, Song G. Cytoskeletal control of nuclear morphology and stiffness are required for OPN-induced bone-marrow-derived mesenchymal stem cell migration. Biochem Cell Biol. 2019;97(4):463–470. doi:10.1139/bcb-2018-0263
   PubMedGoogle Scholar
• Schmidt A, Ladage D, Schinkothe T, et al. Basic fibroblast growth factor controls migration in human mesenchymal stem cells. Stem Cells. 2006;24(7):1750–1758. doi:10.1634/stemcells.2005-0191
   PubMed Web of Science ®Google Scholar
• Zhou SB, Wang J, Chiang CA, Sheng LL, Li QF. Mechanical stretch upregulates SDF-1alpha in skin tissue and induces migration of circulating bone marrow-derived stem cells into the expanded skin. Stem Cells. 2013;31(12):2703–2713. doi:10.1002/stem.1479
   PubMed Web of Science ®Google Scholar
• Gebreyesus EA, Park A, Guldberg RE, Ong KG. In vitromagnetohydrodynamics system for modulating cell migration. Biomed Phys Eng Express. 2023;9(2):025007. doi:10.1088/2057-1976/acb711
   Web of Science ®Google Scholar
• Ball SG, Shuttleworth CA, Kielty CM. Vascular endothelial growth factor can signal through platelet- derived growth factor receptors. J Cell Biol. 2007;177(3):489–500. doi:10.1083/jcb.200608093
   PubMed Web of Science ®Google Scholar
• Ponte AL, Marais E, Gallay N, et al. The in vitro migration capacity of human bone marrow mesenchymal stem cells: comparison of chemokine and growth factor chemotactic activities. Stem Cells. 2007;25(7):1737–1745. doi:10.1634/stemcells.2007-0054
   PubMed Web of Science ®Google Scholar
• Hagmeijer MH, Korpershoek JV, Crispim JF, et al. The regenerative effect of different growth factors and platelet lysate on meniscus cells and mesenchymal stromal cells and proof of concept with a functionalized meniscus implant. J Tissue Eng Regen Med. 2021;15(7):648–659. doi:10.1002/term.3218
   PubMed Web of Science ®Google Scholar
• Li X, Zhan J, Hou Y, et al. Coenzyme Q10 regulation of apoptosis and oxidative stress in H2O2 induced BMSC death by modulating the Nrf-2/NQO-1 signaling pathway and its application in a model of spinal cord injury. Oxid Med Cell Longev. 2019;2019:6493081. doi:10.1155/2019/6493081
   PubMed Web of Science ®Google Scholar
• Sayad Fathi S, Zaminy A. Stem cell therapy for nerve injury. World J Stem Cells. 2017;9(9):144–151. doi:10.4252/wjsc.v9.i9.144
   PubMed Web of Science ®Google Scholar
• Jin MC, Medress ZA, Azad TD, Doulames VM, Veeravagu A. Stem cell therapies for acute spinal cord injury in humans: a review. Neurosurg Focus. 2019;46(3):E10. doi:10.3171/2018.12.FOCUS18602
   PubMed Web of Science ®Google Scholar
• Wei GJ, An G, Shi ZW, et al. Suppression of MicroRNA-383 enhances therapeutic potential of human bone-marrow-derived mesenchymal stem cells in treating spinal cord injury via GDNF. Cell Physiol Biochem. 2017;41(4):1435–1444. doi:10.1159/000468057
   PubMedGoogle Scholar
• Lv B, Zhang X, Yuan J, et al. Biomaterial-supported MSC transplantation enhances cell-cell communication for spinal cord injury. Stem Cell Res Ther. 2021;12(1):36. doi:10.1186/s13287-020-02090-y
   PubMed Web of Science ®Google Scholar
• Silva D, Sousa RA, Salgado AJ. Hydrogels as delivery systems for spinal cord injury regeneration. Mater Today Biol. 2021;9:100093. doi:10.1016/j.mtbio.2021.100093
   PubMedGoogle Scholar
• Yang W, Yang Y, Yang JY, Liang M, Song J. Treatment with bone marrow mesenchymal stem cells combined with plumbagin alleviates spinal cord injury by affecting oxidative stress, inflammation, apoptotis and the activation of the Nrf2 pathway. Int J Mol Med. 2016;37(4):1075–1082. doi:10.3892/ijmm.2016.2498
   PubMed Web of Science ®Google Scholar
• Boido M, Ghibaudi M, Gentile P, Favaro E, Fusaro R, Tonda-Turo C. Chitosan-based hydrogel to support the paracrine activity of mesenchymal stem cells in spinal cord injury treatment. Sci Rep. 2019;9(1):6402. doi:10.1038/s41598-019-42848-w
   PubMed Web of Science ®Google Scholar
• Pang QM, Chen SY, Xu QJ, et al. Neuroinflammation and scarring after spinal cord injury: therapeutic roles of MSCs on inflammation and Glial Scar. Front Immunol. 2021;12:751021. doi:10.3389/fimmu.2021.751021
   PubMed Web of Science ®Google Scholar
• Peng Z, Gao W, Yue B, et al. Promotion of neurological recovery in rat spinal cord injury by mesenchymal stem cells loaded on nerve-guided collagen scaffold through increasing alternatively activated macrophage polarization. J Tissue Eng Regen Med. 2018;12(3):e1725–e1736. doi:10.1002/term.2358
   PubMed Web of Science ®Google Scholar
• Kim YJ, Seo DH, Lee SH, et al. Conditioned media from human umbilical cord blood-derived mesenchymal stem cells stimulate rejuvenation function in human skin. Biochem Biophys Rep. 2018;16:96–102. doi:10.1016/j.bbrep.2018.10.007
   PubMedGoogle Scholar
• Boido M, Piras A, Valsecchi V, et al. Human mesenchymal stromal cell transplantation modulates neuroinflammatory milieu in a mouse model of amyotrophic lateral sclerosis. Cytotherapy. 2014;16(8):1059–1072. doi:10.1016/j.jcyt.2014.02.003
   PubMed Web of Science ®Google Scholar
• Mead B, Logan A, Berry M, Leadbeater W, Scheven BA. Paracrine-mediated neuroprotection and neuritogenesis of axotomised retinal ganglion cells by human dental pulp stem cells: comparison with human bone marrow and adipose-derived mesenchymal stem cells. PLoS One. 2014;9(10):e109305. doi:10.1371/journal.pone.0109305
   PubMed Web of Science ®Google Scholar
• Teixeira FG, Carvalho MM, Neves-Carvalho A, et al. Secretome of mesenchymal progenitors from the umbilical cord acts as modulator of neural/glial proliferation and differentiation. Stem Cell Rev Rep. 2015;11(2):288–297. doi:10.1007/s12015-014-9576-2
   PubMed Web of Science ®Google Scholar
• Hou L, Cao H, Wang D, et al. Induction of umbilical cord blood mesenchymal stem cells into neuron-like cells in vitro. Int J Hematol. 2003;78(3):256–261. doi:10.1007/BF02983804
   PubMed Web of Science ®Google Scholar
• Fu Q, Liu Y, Liu X, et al. Engrafted peripheral blood-derived mesenchymal stem cells promote locomotive recovery in adult rats after spinal cord injury. Am J Transl Res. 2017;9(9):3950–3966.
   PubMed Web of Science ®Google Scholar
• Lindsay SL, Barnett SC. Therapeutic potential of Niche-specific mesenchymal stromal cells for spinal cord injury repair. Cells. 2021;10(4):901. doi:10.3390/cells10040901
   PubMed Web of Science ®Google Scholar
• Nagaoki T, Kumagai G, Nitobe Y, et al. Comparison of the Anti-inflammatory effects of mouse adipose- and bone-marrow-derived multilineage-differentiating stress-enduring cells in acute-phase spinal cord injury. J Neurotrauma. 2023. doi:10.1089/neu.2022.0470
   PubMed Web of Science ®Google Scholar
• Mammana S, Gugliandolo A, Cavalli E, et al. Human gingival mesenchymal stem cells pretreated with vesicular moringin nanostructures as a new therapeutic approach in a mouse model of spinal cord injury. J Tissue Eng Regen Med. 2019;13(7):1109–1121. doi:10.1002/term.2857
   PubMed Web of Science ®Google Scholar
• Wang W, Huang X, Lin W, et al. Hypoxic preconditioned bone mesenchymal stem cells ameliorate spinal cord injury in rats via improved survival and migration. Int J Mol Med. 2018;42(5):2538–2550. doi:10.3892/ijmm.2018.3810
   PubMed Web of Science ®Google Scholar
• Zhilai Z, Biling M, Sujun Q, et al. Preconditioning in lowered oxygen enhances the therapeutic potential of human umbilical mesenchymal stem cells in a rat model of spinal cord injury. Brain Res. 2016;1642:426–435. doi:10.1016/j.brainres.2016.04.025
   PubMed Web of Science ®Google Scholar
• Hur JW, Cho TH, Park DH, Lee JB, Park JY, Chung YG. Intrathecal transplantation of autologous adipose-derived mesenchymal stem cells for treating spinal cord injury: a human trial. J Spinal Cord Med. 2016;39(6):655–664. doi:10.1179/2045772315Y.0000000048
   PubMed Web of Science ®Google Scholar
• Oh SK, Choi KH, Yoo JY, Kim DY, Kim SJ, Jeon SR. A Phase III clinical trial showing limited efficacy of autologous mesenchymal stem cell therapy for spinal cord injury. Neurosurgery. 2016;78(3):436–447. doi:10.1227/NEU.0000000000001056
   PubMed Web of Science ®Google Scholar
• Satti HS, Waheed A, Ahmed P, et al. Autologous mesenchymal stromal cell transplantation for spinal cord injury: a Phase I pilot study. Cytotherapy. 2016;18(4):518–522. doi:10.1016/j.jcyt.2016.01.004
   PubMed Web of Science ®Google Scholar
• Ahuja CS, Mothe A, Khazaei M, et al. The leading edge: emerging neuroprotective and neuroregenerative cell-based therapies for spinal cord injury. Stem Cells Transl Med. 2020;9(12):1509–1530. doi:10.1002/sctm.19-0135
   PubMed Web of Science ®Google Scholar
• Bryk M, Karnas E, Mlost J, Zuba-Surma E, Starowicz K. Mesenchymal stem cells and extracellular vesicles for the treatment of pain: current status and perspectives. Br J Pharmacol. 2022;179(17):4281–4299. doi:10.1111/bph.15569
   PubMed Web of Science ®Google Scholar
• Hellenbrand DJ, Quinn CM, Piper ZJ, Morehouse CN, Fixel JA, Hanna AS. Inflammation after spinal cord injury: a review of the critical timeline of signaling cues and cellular infiltration. J Neuroinflammation. 2021;18(1):284. doi:10.1186/s12974-021-02337-2
   PubMed Web of Science ®Google Scholar
• Martins BC, Torres BBJ, de Oliveira KM, et al. Association of riluzole and dantrolene improves significant recovery after acute spinal cord injury in rats. Spine J. 2018;18(3):532–539. doi:10.1016/j.spinee.2017.10.067
   PubMed Web of Science ®Google Scholar
• Wallner S, Peters S, Pitzer C, Resch H, Bogdahn U, Schneider A. The Granulocyte-colony stimulating factor has a dual role in neuronal and vascular plasticity. Front Cell Dev Biol. 2015;3:48. doi:10.3389/fcell.2015.00048
   PubMed Web of Science ®Google Scholar
• Ghasemi N, Razavi S, Mardani M, Esfandiari E, Salehi H, Zarkesh Esfahani SH. Transplantation of human adipose-derived stem cells enhances remyelination in lysolecithin-induced focal demyelination of rat spinal cord. Mol Biotechnol. 2014;56(5):470–478. doi:10.1007/s12033-014-9744-2
   PubMed Web of Science ®Google Scholar
• Razavi S, Ghasemi N, Mardani M, Salehi H. Remyelination improvement after neurotrophic factors secreting cells transplantation in rat spinal cord injury. Iran J Basic Med Sci. 2017;20(4):392–398. doi:10.22038/IJBMS.2017.8580
   PubMed Web of Science ®Google Scholar
• Rbia N, Bulstra LF, Lewallen EA, Hovius SER, van Wijnen AJ, Shin AY. Seeding decellularized nerve allografts with adipose-derived mesenchymal stromal cells: an in vitro analysis of the gene expression and growth factors produced. J Plast Reconstr Aesthet Surg. 2019;72(8):1316–1325. doi:10.1016/j.bjps.2019.04.014
   PubMed Web of Science ®Google Scholar
• Vizoso FJ, Eiro N, Cid S, Schneider J, Perez-Fernandez R. Mesenchymal stem cell secretome: toward cell-free therapeutic strategies in regenerative medicine. Int J Mol Sci. 2017;18(9):1852. doi:10.3390/ijms18091852
   PubMed Web of Science ®Google Scholar
• Devanney NA, Stewart AN, Gensel JC. Microglia and macrophage metabolism in CNS injury and disease: the role of immunometabolism in neurodegeneration and neurotrauma. Exp Neurol. 2020;329:113310. doi:10.1016/j.expneurol.2020.113310
   PubMed Web of Science ®Google Scholar
• Gensel JC, Zhang B. Macrophage activation and its role in repair and pathology after spinal cord injury. Brain Res. 2015;1619:1–11. doi:10.1016/j.brainres.2014.12.045
   PubMed Web of Science ®Google Scholar
• Brockie S, Hong J, Fehlings MG. The role of microglia in modulating neuroinflammation after spinal cord injury. Int J Mol Sci. 2021;22(18):9706. doi:10.3390/ijms22189706
   PubMed Web of Science ®Google Scholar
• Miranpuri GS, Bali P, Nguyen J, et al. Role of microglia and astrocytes in spinal cord injury induced neuropathic pain. Ann Neurosci. 2021;28(3–4):219–228. doi:10.1177/09727531211046367
   PubMed Web of Science ®Google Scholar
• Nakajima H, Uchida K, Guerrero AR, et al. Transplantation of mesenchymal stem cells promotes an alternative pathway of macrophage activation and functional recovery after spinal cord injury. J Neurotrauma. 2012;29(8):1614–1625. doi:10.1089/neu.2011.2109
   PubMed Web of Science ®Google Scholar
• Papa S, Vismara I, Mariani A, et al. Mesenchymal stem cells encapsulated into biomimetic hydrogel scaffold gradually release CCL2 chemokine in situ preserving cytoarchitecture and promoting functional recovery in spinal cord injury. J Control Release. 2018;278:49–56. doi:10.1016/j.jconrel.2018.03.034
   PubMed Web of Science ®Google Scholar
• Valle-Prieto A, Conget PA. Human mesenchymal stem cells efficiently manage oxidative stress. Stem Cells Dev. 2010;19(12):1885–1893. doi:10.1089/scd.2010.0093
   PubMed Web of Science ®Google Scholar
• Buzoglu HD, Burus A, Bayazit Y, Goldberg M. Stem cell and oxidative stress-inflammation cycle. Curr Stem Cell Res Ther. 2023;18(5):641–652. doi:10.2174/1574888X17666221012151425
   PubMed Web of Science ®Google Scholar
• DeSantiago J, Bare DJ, Banach K. Ischemia/Reperfusion injury protection by mesenchymal stem cell derived antioxidant capacity. Stem Cells Dev. 2013;22(18):2497–2507. doi:10.1089/scd.2013.0136
   PubMed Web of Science ®Google Scholar
• Mahrouf-Yorgov M, Augeul L, Da Silva CC, et al. Mesenchymal stem cells sense mitochondria released from damaged cells as danger signals to activate their rescue properties. Cell Death Differ. 2017;24(7):1224–1238. doi:10.1038/cdd.2017.51
   PubMed Web of Science ®Google Scholar
• Kim Y, Jo SH, Kim WH, Kweon OK. Antioxidant and anti-inflammatory effects of intravenously injected adipose derived mesenchymal stem cells in dogs with acute spinal cord injury. Stem Cell Res Ther. 2015;6:229. doi:10.1186/s13287-015-0236-5
   PubMed Web of Science ®Google Scholar
• Stavely R, Nurgali K. The emerging antioxidant paradigm of mesenchymal stem cell therapy. Stem Cells Transl Med. 2020;9(9):985–1006. doi:10.1002/sctm.19-0446
   PubMed Web of Science ®Google Scholar
• Sobrido-Camean D, Barreiro-Iglesias A. Role of Caspase-8 and Fas in cell death after spinal cord injury. Front Mol Neurosci. 2018;11:101. doi:10.3389/fnmol.2018.00101
   PubMed Web of Science ®Google Scholar
• Cai W, Shen WD. Anti-apoptotic mechanisms of acupuncture in neurological diseases: a review. Am J Chin Med. 2018;46(3):515–535. doi:10.1142/S0192415X1850026X
   PubMed Web of Science ®Google Scholar
• Wu S, Cui G, Shao H, Du Z, Ng JC, Peng C. The cotransplantation of olfactory ensheathing cells with bone marrow mesenchymal stem cells exerts antiapoptotic effects in adult rats after spinal cord injury. Stem Cells Int. 2015;2015:516215. doi:10.1155/2015/516215
   PubMed Web of Science ®Google Scholar
• Isele NB, Lee HS, Landshamer S, et al. Bone marrow stromal cells mediate protection through stimulation of PI3-K/Akt and MAPK signaling in neurons. Neurochem Int. 2007;50(1):243–250. doi:10.1016/j.neuint.2006.08.007
   PubMed Web of Science ®Google Scholar
• Dasari VR, Veeravalli KK, Dinh DH. Mesenchymal stem cells in the treatment of spinal cord injuries: a review. World J Stem Cells. 2014;6(2):120–133. doi:10.4252/wjsc.v6.i2.120
   PubMedGoogle Scholar
• Li Y, Lucas-Osma AM, Black S, et al. Pericytes impair capillary blood flow and motor function after chronic spinal cord injury. Nat Med. 2017;23(6):733–741. doi:10.1038/nm.4331
   PubMed Web of Science ®Google Scholar
• Lu Y, Zhou Y, Zhang R, et al. Bone mesenchymal stem cell-derived extracellular vesicles promote recovery following spinal cord injury via improvement of the integrity of the blood-spinal cord barrier. Front Neurosci. 2019;13:209. doi:10.3389/fnins.2019.00209
   PubMed Web of Science ®Google Scholar
• Morita T, Sasaki M, Kataoka-Sasaki Y, et al. Intravenous infusion of mesenchymal stem cells promotes functional recovery in a model of chronic spinal cord injury. Neuroscience. 2016;335:221–231. doi:10.1016/j.neuroscience.2016.08.037
   PubMed Web of Science ®Google Scholar
• Filous AR, Silver J. ”Targeting astrocytes in CNS injury and disease: a translational research approach”. Prog Neurobiol. 2016;144:173–187. doi:10.1016/j.pneurobio.2016.03.009
   PubMed Web of Science ®Google Scholar
• Kwon BK, Fisher CG, Dvorak MF, Tetzlaff W. Strategies to promote neural repair and regeneration after spinal cord injury. Spine (Phila Pa 1976). 2005;30(17 Suppl):S3–13. doi:10.1097/01.brs.0000175186.17923.87
   Web of Science ®Google Scholar
• Wu X, Xu XM. RhoA/Rho kinase in spinal cord injury. Neural Regen Res. 2016;11(1):23–27. doi:10.4103/1673-5374.169601
   PubMed Web of Science ®Google Scholar
• Kwon BK, Liu J, Messerer C, et al. Survival and regeneration of rubrospinal neurons 1 year after spinal cord injury. Proc Natl Acad Sci U S A. 2002;99(5):3246–3251. doi:10.1073/pnas.052308899
   PubMed Web of Science ®Google Scholar
• Schwab ME, Strittmatter SM. Nogo limits neural plasticity and recovery from injury. Curr Opin Neurobiol. 2014;27:53–60. doi:10.1016/j.conb.2014.02.011
   PubMed Web of Science ®Google Scholar
• Urdzikova LM, Ruzicka J, LaBagnara M, et al. Human mesenchymal stem cells modulate inflammatory cytokines after spinal cord injury in rat. Int J Mol Sci. 2014;15(7):11275–11293. doi:10.3390/ijms150711275
   PubMed Web of Science ®Google Scholar
• Bradbury EJ, Burnside ER. Moving beyond the glial scar for spinal cord repair. Nat Commun. 2019;10(1):3879. doi:10.1038/s41467-019-11707-7
   PubMedGoogle Scholar
• Sultan I, Lamba N, Liew A, et al. The safety and efficacy of steroid treatment for acute spinal cord injury: a systematic review and meta-analysis. Heliyon. 2020;6(2):e03414. doi:10.1016/j.heliyon.2020.e03414
   PubMed Web of Science ®Google Scholar
• Gordon T. The role of neurotrophic factors in nerve regeneration. Neurosurg Focus. 2009;26(2):E3. doi:10.3171/FOC.2009.26.2.E3
   PubMedGoogle Scholar
• Ankeny DP, McTigue DM, Jakeman LB. Bone marrow transplants provide tissue protection and directional guidance for axons after contusive spinal cord injury in rats. Exp Neurol. 2004;190(1):17–31. doi:10.1016/j.expneurol.2004.05.045
   PubMed Web of Science ®Google Scholar
• Anderson MA, O’Shea TM, Burda JE, et al. Required growth facilitators propel axon regeneration across complete spinal cord injury. Nature. 2018;561(7723):396–400. doi:10.1038/s41586-018-0467-6
   PubMed Web of Science ®Google Scholar
• Okuda A, Horii-Hayashi N, Sasagawa T, et al. Bone marrow stromal cell sheets may promote axonal regeneration and functional recovery with suppression of glial scar formation after spinal cord transection injury in rats. J Neurosurg Spine. 2017;26(3):388–395. doi:10.3171/2016.8.SPINE16250
   PubMed Web of Science ®Google Scholar
• Lee SH, Kim Y, Rhew D, et al. Effect of the combination of mesenchymal stromal cells and chondroitinase ABC on chronic spinal cord injury. Cytotherapy. 2015;17(10):1374–1383. doi:10.1016/j.jcyt.2015.05.012
   PubMed Web of Science ®Google Scholar
• Hellal F, Hurtado A, Ruschel J, et al. Microtubule stabilization reduces scarring and causes axon regeneration after spinal cord injury. Science. 2011;331(6019):928–931. doi:10.1126/science.1201148
   PubMed Web of Science ®Google Scholar
• Lv C, Zhang T, Li K, Gao K. Bone marrow mesenchymal stem cells improve spinal function of spinal cord injury in rats via TGF-beta/Smads signaling pathway. Exp Ther Med. 2020;19(6):3657–3663. doi:10.3892/etm.2020.8640
   PubMed Web of Science ®Google Scholar